Published in J Urol on May 01, 2001
Curing metastatic testicular cancer. Proc Natl Acad Sci U S A (2002) 1.92
A case series of transformation of teratoma to primitive neuroectodermal tumor: evolving management of a rare malignancy. Rare Tumors (2014) 0.91
Teratoma with somatic-type malignant components of the testis. A review and an update. Virchows Arch (2012) 0.87
Central primary primitive neuroectodermal tumor (cPNET) arising from an ovarian mature cystic teratoma in pregnancy: A case report and review of medical literature. Gynecol Oncol Case Rep (2013) 0.83
Retroperitoneal teratoma with somatic malignant transformation: a papillary renal cell carcinoma in a testicular germ cell tumour metastasis following platinum-based chemotherapy. BMC Urol (2013) 0.80
Primitive Neuro Ectodermal Tumor Arising in a Testicular Teratoma with Retroperitoneal Metastasis: A Case Report and Review of Literature. Urol Case Rep (2017) 0.75
[Primitive neuroectodermal tumor of the testis. Molecular analysis and discussion of genesis]. Pathologe (2013) 0.75
TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res (2003) 29.26
The TRANSFAC system on gene expression regulation. Nucleic Acids Res (2001) 13.63
Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol (2010) 5.96
Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol (1999) 5.95
CYGD: the Comprehensive Yeast Genome Database. Nucleic Acids Res (2005) 5.25
Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med (1977) 4.91
Drugs five years later. Cisplatin. Ann Intern Med (1984) 3.69
Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med (1987) 3.52
Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E (CD103)-deficient mice. J Immunol (1999) 3.21
Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. J Clin Oncol (2001) 3.06
Breast self-examination practices and breast-cancer stage. N Engl J Med (1978) 3.03
A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J Clin Oncol (1992) 2.90
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol (2000) 2.73
Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer. Ann Intern Med (1990) 2.64
Adverse relationship between blood transfusions and survival after colectomy for colon cancer. Cancer (1985) 2.24
No evidence of acute cardiovascular complications of chemotherapy for testicular cancer: an analysis of the Testicular Cancer Intergroup Study. J Clin Oncol (1992) 2.11
Combination chemotherapy in disseminated testicular cancer: the Indiana University experience. Semin Oncol (1979) 1.91
Late relapse of testicular cancer. J Clin Oncol (1995) 1.87
The development of non-germ cell malignancies within germ cell tumors. A clinicopathologic study of 11 cases. Cancer (1984) 1.85
A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol (1992) 1.84
Breast self-examination practices and breast cancer survival. Cancer (1984) 1.81
Chemotherapy of disseminated testicular cancer. A random prospective study. Cancer (1980) 1.79
High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables. J Clin Oncol (1996) 1.77
Gefitinib in patients with chemo-sensitive and chemo-refractory relapsed small cell cancers: a Hoosier Oncology Group phase II trial. Lung Cancer (2006) 1.77
Hemopoietic progenitor cells of W anemic mice studies in vivo and in vitro. J Cell Physiol (1968) 1.74
Intrapleural therapy for malignant pleural effusions. A randomized comparison of bleomycin and tetracycline. Chest (1991) 1.72
Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor. J Clin Oncol (1998) 1.72
Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J Clin Oncol (1997) 1.70
Decision analysis for avoiding postchemotherapy surgery in patients with disseminated nonseminomatous germ cell tumors. J Clin Oncol (1997) 1.70
Management of postchemotherapy residual mass in patients with advanced seminoma: Indiana University experience. J Clin Oncol (1989) 1.68
Molecular evidence for the independent origin of extra-ovarian papillary serous tumors of low malignant potential. J Natl Cancer Inst (2001) 1.65
Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation. Cancer Res (2001) 1.64
Primitive neuroectodermal tumors arising in testicular germ cell neoplasms. Am J Surg Pathol (1997) 1.64
Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. J Clin Oncol (1995) 1.60
Hepatic resection of metastatic testicular carcinoma: a further update. Ann Surg Oncol (1999) 1.59
Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder. Cancer Res (1999) 1.58
Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy. N Engl J Med (1979) 1.57
Tumors of the small intestine. World J Surg (2000) 1.54
Decreased liver and lung drug-metabolizing activity in mice treated with Corynebacterium parvum. Cancer Res (1976) 1.53
Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. J Clin Oncol (1994) 1.51
Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: a randomized trial of the Southeastern Cancer Study Group. J Clin Oncol (1993) 1.51
Adrenalectomy via the dorsal approach: a benchmark for laparoscopic adrenalectomy. J Urol (1995) 1.50
Legionnaires' disease in patients with associated serious disease. Ann Intern Med (1979) 1.50
Cisplatin-based combination chemotherapy for disseminated germ cell tumors: long-term follow-up. J Clin Oncol (1988) 1.49
Splenic rupture during occlusion of the porta hepatis in resection of tumors with vena caval extension. J Urol (1994) 1.48
Staging relationships and outcome in early stage testicular cancer: a report from the Testicular Cancer Intergroup Study. J Urol (1991) 1.47
Metastatic patterns of choroidal melanoma. Cancer (1974) 1.45
Tumors of the esophagus. World J Surg (2000) 1.44
Adjuvant bleomycin, etoposide and cisplatin in pathological stage II non-seminomatous testicular cancer. the Indiana University experience. Eur J Cancer (2000) 1.42
Cholinergic and adrenergic interactions in the thermoregulatory centers of the rat. Brain Res (1969) 1.41
Advanced testicular cancer: update for urologists. J Urol (1998) 1.41
Hematologic malignancies associated with primary mediastinal germ-cell tumors. Ann Intern Med (1985) 1.41
Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group. J Clin Oncol (1994) 1.39
The clinical implications of procedural deviations during orchiectomy for nonseminomatous testis cancer. J Urol (1995) 1.39
Testicular cancer as a model for a curable neoplasm: The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res (1981) 1.37
The value of cost projections. Health Aff (Millwood) (1995) 1.37
Improved chemotherapy in disseminated testicular cancer. J Urol (1977) 1.37
Long term effect of cis-diamminedichloride platinum (CDDP) on renal function and structure in man. Cancer (1978) 1.35
Blood transfusions and survival after lung cancer resection. Am J Surg (1985) 1.33
Fine needle aspiration of the breast. Importance of the aspirator. Acta Cytol (1987) 1.33
Fertility after chemotherapy for testicular cancer. J Clin Oncol (1983) 1.32
The pathology of late recurrence of testicular germ cell tumors. Am J Surg Pathol (2000) 1.30
Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. N Engl J Med (1987) 1.30
Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections. J Clin Oncol (1993) 1.29
Distribution of nodal metastases in nonseminomatous testis cancer. J Urol (1982) 1.29
Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J Clin Oncol (1997) 1.26
Primary aldosteronism: diagnosis, localization, and treatment. Ann Intern Med (1979) 1.26
Testicular cancer: the quest continues. J Natl Cancer Inst (1988) 1.25
Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. Cancer Res (1974) 1.25
Core-cutting needle biopsy for the diagnosis of breast cancer. Am J Surg (1982) 1.25
Tumors of the rectum and anal canal. World J Surg (2000) 1.24
Bilateral testicular tumors: management and outcome in 21 patients. Cancer (1998) 1.23
Mangement of infantile esotropia. Am J Ophthalmol (1976) 1.23
Electrophoretic comparison of endonuclease-digested plasmids from Neisseria gonorrhoeae. J Bacteriol (1976) 1.23
Retrospective analysis of the utility of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in pancreatic masses, using a 22-gauge or 25-gauge needle system: a multicenter experience. Endoscopy (2009) 1.23
Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol. J Clin Oncol (1991) 1.22
Cisplatin as first-line therapy for metastatic breast cancer. J Clin Oncol (1988) 1.22
The role of maintenance therapy in disseminated testicular cancer. N Engl J Med (1981) 1.22
Complications of post-chemotherapy retroperitoneal lymph node dissection. J Urol (1995) 1.21
Vertical rectus muscle augmented transposition in Duane syndrome. J AAPOS (2001) 1.20
The swi4+ gene of Schizosaccharomyces pombe encodes a homologue of mismatch repair enzymes. Nucleic Acids Res (1992) 1.18
Validation of a prediction model and its predictors for the histology of residual masses in nonseminomatous testicular cancer. J Urol (2001) 1.17
Late relapse of clinical stage I testicular cancer. J Urol (1995) 1.17
Tumors of the oral cavity and pharynx. World J Surg (2000) 1.17